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1131-142 Predictors of Left Atrial Appendage Thrombogenesis in 
Patients Undergoing Transesophageal 
Echocardiography-Guided Cardioversion for Atrial 
Fibrillation and Flutter
Faisal O. Alatawi, Joseph Malouf, Chandrasekaran Krishnaswarmy, Saeed A. Al Ahmari, 
Brenda S. Moon, Charles J. Bruce, Naser M. Ammash, Mayo Clinic, Rochester, MN
Background: The clinical and echocardiographic predictors of left atrial appendage (LAA)
thrombogenesis in patients (pts) with non rheumatic atrial fibrillation (NRAF) or flutter
AFL remain unclear.
Methods:. Between May 2000 and 2003 ,75 patients with LAA thrombi or dense sponta-
neous echo contrast (DSEC) prior to scheduled transesophageal echocardiography
(TEE) guided cardioversion (group 1) were compared to a matched group (for age, gen-
der, diabetes, type of arrhythmia, sedation during TEE) without LAA thrombi or DSEC
(group2). pts with mitral valve stenosis, congenital heart disease, or prosthetic valve,
were excluded..
Results:. Univariate predictors of LAA thrombi and DSEC are summarized in the table
below. 
On multivariate analysis only NYHA class III& IV and LAA emptying velocity < 20 cm \ s 
were independent predictors of LAA thrombi and \or LAA DSEC.
Conclusion: In patients scheduled to undergo TEE guided cardioversion., both advanced 
symptoms of heart failure and severe mechanical left atrial appendage dysfunction are 
independently predictive of a thrombogenic milieu within the LAA
1131-143 The Fate of Left Atrial Thrombi: A Prospective and Serial 
Follow-Up Over Three Years With Transesophageal 
Echocardiography and Cerebral Magnetic Resonance 
Imaging
Peter Bernhardt, Harald Schmidt, Christoph Hammerstingl, Berndt Luederitz, Heyder 
Omran, University of Bonn, Bonn, Germany
Background: Patients (pts) with atrial fibrillation (AF) and atrial thrombi are at a high risk
for stroke. However, there are no prospective long-term data on the prognosis of pts
available. The aims of this prospective study were (1) to assess the prognosis of pts with
atrial thrombi and (2) to evaluate the incidence of cerebral embolism and death. 
Methods: 21 consecutive pts with AF and atrial thrombi located in the left atrial append-
age (LAA) were enrolled in our study. All pts received oral anticoagulation during the
study period (INR>2 was regarded as effective anticoagulation). The pts underwent fol-
lowing examinations during the three years observation period: transthoracic (TTE) and
transesophageal echocardiography (TEE), cerebral MRI, control of the anticoagulation
status and neurological examination.
Results: 2 [10%] pts died due to cerebrovascular events during the follow-up period. 8
[38%] pts had cerebral embolism as documented with neuological deficits during the
observation period. 15 [71%] thrombi dissolved under continued oral anticoagulation. Pts
with and without embolism did not differ for age, sex, cardiovascular risk factors and his-
tory of embolism. Pts with thrombus resolution had significantly smaller thrombi (1.3 ±
0.6 cm vs. 1.7 ± 0.6 cm length and 0.6 ± 0.2 vs. 1.0 ± 0.5 width, p=0.03) and less often
echogenic thrombi (8 [53%] vs. 6 [100%], p=0.02).
Conclusion: Pts with AF and LAA thrombi have a high long term risk for cerebral embo-
lism and/or death [52%] (17% per year). A high percentage of thrombi disappear under
continued oral anticoagulation therapy [71%]. Independent predictors for thrombus reso-
lution are thrombus size and echogenicity.
1131-144 Significant Mitral Regurgitation Is Protective Against 
Left Atrial Spontaneous Echo Contrast and 
Thrombogenesis in Atrial Fibrillation: An ACUTE Trial 
Ancillary Study
John A. Sallach, Richard A. Grimm, Susan E. Jasper, Jianbo Li, Elizabeth A. Lieber, 
Allan L. Klein, Cleveland Clinic Foundation, Cleveland, OH
Background:The relationship between mitral regurgitation (MR) and left atrial spontane-
ous echo contrast (LA-SEC)/thrombus (THR) in atrial fibrillation (AF) remains controver-
sial. We sought to determine if significant MR protects against the development of LA-
SEC/THR in AF.
Methods: The Assessment of Cardioversion Using Transesophageal Echocardiography
(ACUTE) Trial, randomized 1,222 patients with AF to TEE-guided cardioversion or con-
ventional treatment. TEE with 6 month follow-up was available in 469 (38%) patients.
TEEs were evaluated for LA-THR and LA-SEC was graded as absent, mild or severe.
Patients were divided according to the presence of MR on TEE (MR > 3+ was significant
and MR < 2+ was insignificant). Baseline clinical variables and TEE parameters were
compared between these two groups.
Results: MR < 2+ was found in 443 (94.5%) patients (mean age 66 ± 12 yrs) while 26
(5.5%) patients (mean age 64 ± 13 yrs) had MR > 3+. There were no differences in base-
line characteristics with the exception of increased AF duration in patients with MR < 2+
(13 [5-48] days vs. 10 [5-34] days, p=0.03). On TEE, LA-SEC/THR was noted in 252
(59%) patients with MR < 2+ compared to only 6 (27%) patients with MR > 3+ (p=0.001)
(Table 1). After adjusting for confounders MR > 3+ was found to be protective against LA-
SEC/THR.
Conclusions: In AF, significant MR is protective against the formation of LA-SEC/THR.
These findings should be considered in the TEE risk stratification of AF patients.
1131-145 Impact of Percutaneous Left Atrial Appendage 
Transcatheter Occlusion Device on Left Atrial Structure 
and Function: Six-Month Echocardiographic Follow-Up
Ibrahim R. Hanna, Gerald P. Kolm, Randolph Martin, Peter Block, Emory University 
School of Medicine, Atlanta, GA
Background: Percutaneous left atrial appendage transcatheter occlusion (PLAATO) is a
novel device designed to seal the neck of the left atrial appendage with the purpose of
reducing embolization in patients with atrial fibrillation intolerant of coumadin. The impact
of deployment of this device on adjacent structures has not been reported.
Methods: Patients participating in the ongoing study for evaluation of PLAATO in stroke
prevention at 2 hospitals were enrolled. Transesophageal echocardiograms at baseline,
1, and 6 months, were reviewed to measure left atrial (LA) and left upper pulmonary vein
(LUPV) dimensions, degree of mitral regurgitation (MR), stability and flow around the
device, peak mitral valve (MV) E-wave velocity, and peak systolic and diastolic flow veloc-
ities in the LUPV. Data were analyzed by a linear mixed model for repeated measures.
Results: 11 patients (mean age of 72 ± 7 years) completed 6 months of follow-up. LUPV
diameter (mean: 1.55, 1.61, 1.54 cm, p=0.13), peak systolic (mean: 0.38, 0.34, 0.31 m/
sec, p=0.72), and diastolic flow velocities (mean: 0.39, 0.40, 0.42 m/sec, p=0.46) did not
differ over the follow-up period. LA size, degree of MR, and MV peak E-wave velocities
(mean: 0.94, 0.94, 0.82 m/sec, p=0.58) showed no significant change from baseline. The
devices remained stable with minimal residual flow around them.
Conclusion: PLAATO achieved an adequate seal of the neck of the left atrial appendage
without significant effect on the structure or function of the LA and LUPV. 
1131-146 Serial Echocardiographic Follow-Up of Percutaneous 
Left Atrial Appendage Transcatheter Occlusion 
(PLAATOTM) in Patients With Atrial Fibrillation
Athena Poppas, Toshiko Nakai, Horst Sievert, Linda Crouse, Bruce L. Macrum, Kimberly 
Krabill, Sandra Gan, Randolph Martin, Heyder Omran, Mauro Pepi, Fabio Sgura, 
Christian Seiler, Linda Clarke, Richard Kutnick, David Rubenson, Bryan Dias, Mark 
Reisman, Rhode Island Hospital, Providence, RI
Background: In patients (pts) with non-rheumatic AF, over 90% of thrombi form in the
left atrial appendage (LAA). For pts who cannot take warfarin, a novel transcather device
was designed to mechanically occlude the LAA.
Methods: 101 pts (age = 71±7 yrs) with AF, high risk for thromboembolism, via clinical
(CHF, DM, HTN, TIA/CVA) or TEE (dense spontaneous echo contrast or LAA emptying
velocities <20 cm/sec) criteria were enrolled at 12 sites. Screening TEE ruled out LAA
clot. A PLAATO device (ev3) was delivered under fluoroscopic and TEE guidance to the
LAA through a 12 Fr transseptal sheath. TTEs were performed at baseline 1 week, 1 mo,
6 mos and 12 mos of follow-up. Color Doppler assessed mitral regurgitation and shunt-
ing.
Results: 64 pts had 151 TTEs evaluated by an independent core laboratory (AP). Base-
line LVEF = 51.2±9.4% and LA diameter = 4.6±0.6 cm. Mitral regurgitation (MR) was
trace-mild in 77%, moderate in 9%, severe in 1%. No pre-specified device complications
were noted on f/u: worsening mitral regurgitation; device migration or perforation; mobile
thrombus. Of 101 pts, 5 intra-procedural pericardial effusions were noted and treated;
covariate Control
N=75
Study
N=75
P value
Duration of arrhythmia >4weeks % 41% 74% <0.0001
New York heart association (NYHA) class III &IV % 12.5% 39.5% 0.0004
Prior history of transient ischemic attack or 
cerebrovascular accident %
1.3% 10.6% 0.016
LAA emptying velocity < 20cm \s % 1.5% 92.5% <0.0001
Left ventricular ejection fraction, mean ± SD 53 ±13 41±16 <0.0001
systolic fraction of pulmonary flow velocity time 
integral (cm) mean ±SD
0.45 ± 0.12 0.3 ±1 0.08 <0.0001
Table 1. Transesophageal Echocardiogram Findings According to Presence or 
Absence of Significant MR
MR <= 2+(n = 443) MR => 3+(n = 26) p Value
Any LA-SEC 57% 23% <0.001
Mild LA-SEC 40% 12% 0.007
Severe LA-SEC 15% 12% 0.830
LA-THR 13% 4% 0.18
LA-SEC/THR 59% 28% 0.001
Baseline
mean ± sd (n)
1 month
mean ± sd (n)
6 months
mean ± sd (n)
p value
Heart rate
(beats/mn)
78.5 ± 12.5 (11) 81.7 ±13.3 (10) 77.3 ± 13.2 (10) 0.584
LUPV diameter
(cm)
1.55 ± 0.19 (11) 1.61 ± 0.16 (9) 1.54 ± 0.17 (10) 0.13
MV E wave*
(m/sec)
0.94 ± 0.35 (10) 0.94 ± 0.20 (6) 0.82 ± 0.47 (8) 0.581
LUPV S-wave*
(m/sec)
0.38 ± 0.22 (11) 0.34 ± 0.23 (8) 0.31 ± 0.14 (9) 0.716
LUPV D-wave*
(b>m/sec)
0.39 ± 0.14 (10) 0.40 ± 0.19 (8) 0.42 ± 0.18 (9) 0.463
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after an average 10 mos of follow-up, 3 deaths, 2 TIAs and 2 CVAs.
Conclusion: 1). Serial TTE noted stable cardiovascular structure and function after LAA
device placement. 2) On TTE f/u, periprocedural PEs were the only serious complica-
tions noted. 3) A larger study with longer-term f/u is needed to determine PLAATO's effi-
cacy to reduce cardioembolic stroke.
1131-147 Thoracic Aorta Atherosclerosis Burden Index Predicts 
Coronary Artery Disease in Patients Undergoing 
Transesophageal Echocardiography
Alexandra A. Frogoudaki, John Barbetseas, Constadina Aggeli, Demosthenes 
Panagiotakos, Christos Pitsavos, Pavlos Toutouzas, Christodoulos Stefanadis, 
Hippokration Hospital, Athens University, Athens, Greece
Background: The relationship between thoracic aorta atherosclerosis (TAA) and coronary
artery disease (CAD) has been shown by previous studies.The aim of this study was to
show the quantitative relationship between TAA and CAD in patients undergoing TEE.
Methods:We prospectively studied 246 patients (149 men,age 57.9±11.83 years, 97
women,age 56.9±12.33 years, p=0.54), who underwent TEE and coronary angiogram.
Age, sex, standard risk factors for CAD were assessed. TEE was performed in a three-
month period around the coronary angiogram. TEE studies have been analysed and
ascending aorta, aortic arch and descending aorta were graded independently as follow-
ing: Normal Intima: Grade I(points 0), Intima thickening without plaques: Grade II (point
1), One plaque<3mm: Grade IIIA(points 2), More than one plaque3mm: Grade IV(points
4), Large mobile or protruding plaque(s): Grade V (points 5). TAA grade was defined as
the grade of the thoracic aortic segment with the most severe atherosclerosis. TAA bur-
den index (TAABI) was defined as the sum of the points that have been awarded to each
segment.
Results: Eighty-four pts (54 men) had CAD. When TAA was examined independently for
each segment of the aorta, it was an independent factor for predicting CAD: for ascend-
ing aorta the possibility of prediction was increased 90% (OD:1.90, CI 95%: 1.26-2.85),
for aortic arch was tri-folded (OD: 3.03, CI 95%: 2.08-4.40) and for descending aorta it
was increased 70% (OD: 1.70, CI 95%: 1.27-2.26).ROC curve analysis showed that
TAABI had the better specificity and sensitivity in predicting CAD. A TAABI cut-off point
value more than 6 is associated with 20-fold increase of possibility of CAD existence. The
specificity of TAABI value >6 in the prediction of CAD is 88%, the sensitivity is 81%, the
positive predictive value is 77% and the negative predictive value is 90%.
Conclusion: Thoracic aorta atherosclerosis burden index is an easy to obtain by TEE
parameter. A TAABI value more than 6 is an accurate index for CAD prediction implying
that severe TAA is strongly related to CAD while it is rather safe to assume that patients
with no TAA or mild TAA do not have angiographically significant CAD.
1131-148 Is Atherosclerotic Vascular Disease Associated With 
Left Ventricular Diastolic Function in Subjects With 
Normal Systolic Function? A Population-Based 
Transesophageal Echocardiographic Study
Yoram Agmon, Irene Meissner, A. J. Tajik, James B. Seward, Tanya M. Petterson, Teresa 
J.H. Christianson, David O. Wiebers, Bijoy K. Khandheria, Mayo Clinic and Mayo 
Foundation, Rochester, MN
Background: The role of atherosclerosis in the pathogenesis of left ventricular (LV) dias-
tolic dysfunction in subjects with preserved LV systolic function is unclear.
Methods: Transesophageal echocardiography was performed in 388 subjects, a sample
of the Olmsted County (MN) population. The relationship between clinical coronary
artery disease (CAD), aortic atherosclerotic plaques, and LV diastolic function (mitral E/A
ratio, deceleration time [DT], mitral E/annular e' velocity ratio, and left atrial volume [LAV;
measured by transthoracic echocardiography]) were examined in 303 subjects with sinus
rhythm and normal LV systolic function (age 66±10 yrs; 48% men).
Results: The table displays the absolute difference (DT) or % change (E/A, E/e', LAV) (&
95% confidence intervals) of LV diastolic parameters in relation to clinical and plaque
variables (*p<0.05; †p<0.01; ‡p<0.001; §p values for 3 degrees of plaque thickness,
compared with no plaques). Greater plaque thickness was associated with greater dias-
tolic impairment, but these associations were not significant after adjusting for age, gen-
der, and heart rate (p values >0.05). CAD was only associated with increased LAV
(p=0.03), adjusting for age, gender, and heart rate.
Conclusions: Clinical and anatomical atherosclerosis are not independently associated
with LV diastolic function at rest in subjects with normal LV systolic function, thereby
questioning the role of atherosclerosis in the pathogenesis of isolated LV diastolic dys-
function.
1131-149 Reduced Coronary Flow Reserve in the Coronary Sinus 
Is a Predictor of Hemodynamically Significant Stenoses 
of the Left Coronary Artery Territory
Alexander V. Vrublevsky, Alla A. Boshchenko, Rostislav S. Karpov, Cardiology Research 
Institute, Tomsk, Russian Federation
The aim of our study was the detection of hemodynamically significant stenoses of the
left coronary artery (LCA) territory using transesophageal Doppler assessment of coro-
nary flow reserve (CFR) in the coronary sinus (CS).
Methods: We studied 65 CAD pts (men, mean age 51±8 years): 38 – with isolated left
anterior descending artery (LAD) or left circumflex artery (Cx) stenosis >50%; 27 – with
both LAD and Cx stenoses >50%. The control group consisted of 31 healthy volunteers
(men, mean age 34±5 years). Transesophageal Doppler assessment of coronary blood
flow in the CS was performed at baseline and after intravenous dipyridamole (0,56 mg/kg
for 4 minutes) using ultrasound diagnostic systems HDI 5000 SonoCT and Ultramark 9
HDI CV (Philips-ATL). CFR in the CS was calculated in two ways: 1) as ratio of hyperemic
to baseline peak antegrade flow velocity (CFR by Vp); 2) as ratio of hyperemic to base-
line volume blood flow velocity (CFR by VBF). The level of the CBF<2 in both ways of cal-
culation was diagnosed as reduced.
Results: CAD pts compared to healthy volunteers had significantly lower CFR in the CS
both by Vp (1,51±0,44 and 2,57±0,79; p<0,001) and VBF (2,21±1,18 and 5,43±2,83,
p<0,001). Sensitivity and specificity of CFR<2 in the CS as a predictor of hemodynami-
cally significant stenoses of the LCA were for Vp 89% and 76%, and for VBF – 49% and
97%, respectively. CFR <2 in the CS by Vp was registered in 96% of CAD pts with two-
vessel lesion and in 84% of CAD pts with single-vessel lesion, while CFR <2 in the CS by
VBF was revealed in 85% of CAD pts with two-vessel lesion and only in 26% of CAD pts
with single-vessel lesion. Sensitivity and specificity of CFR <2 in the CS by VBF in the
diagnostics of hemodynamically significant two-vessel lesion of the LCA were 85% and
84%.
Conclusion: Thus, the reduced CFR in the CS is a sensitive and specific predictor of
LCA stenoses. A decrease of CFR <2 in the CS both by Vp and VBF is a predictor of
hemodynamically significant two-vessel lesion of the LCA, while a decrease of CFR <2 in
the CS only by Vp is a predictor of single-vessel lesion of the LCA.
1131-150 Right Ventricular Dysfunction on Preoperative 
Transesophageal Echocardiography Predicted Poor 
Outcomes of Cardiac Surgery
Svetlana Barbarash, Craig Saunders, Ravi Karanam, Thomas Prendergast, Daniel 
Goldstein, Fred Sardari, Paul Burns, Simon Cheung, Marc Cohen, Chunguang Chen, 
Newark Beth Israel Medical Center, Newark, NJ
Background:
Left ventricular (LV) dysfunction increases the risk for cardiac surgery. Few data were
available for evaluation of relationship between right ventricular (RV) dysfunction and out-
come of cardiac surgery. This study was to examine the effect of RV dysfunction on out-
comes of cardiac surgery.
Method:
From a database of cardiac surgical outcomes in patients with non-emergency coronary
bypass surgery (CABG) or valve surgery with or without CABG between 4/1999 and 11/
2001, 767 consecutive patients who had pre-operative transesophageal echocardio-
graphy (TEE) were included in the study. RV dysfunction on TEE was graded on a scale
of 0 to 3 (0 - normal, 1 - mild, 2 - moderate, 3 - severe) without knowledge of surgical out-
comes.
Results:
There were 496 patients with CABG only, 271 patients with valve surgery with or without
CABG (Table). The overall 30-day mortality of cardiac surgery was 4.3% (8.1% for the
combined valve and CABG, 2.2% for CABG only). RV function correlated significantly
with surgical mortality (Rank r=0.97, p<0.001). Multi-variant analysis revealed that RV
function, LV ejection fraction, pulmonary artery pressure, type of cardiac surgery are
independent parameters that predicted surgical mortality.
Conclusions:
RV dysfunction was associated with a significant increase in cardiac surgical mortality,
particularly in patients with valve surgery with or without CABG. Thus, RV function should
be considered as an important parameter in selecting patients for cardiac surgery. 
Echocardiographic Assessment
Baseline
n=64
1 wk
n=16
1 month
n=36
6 mo
n=26
12 mo
n=9
LVEF 51.2 ± 9.4% 51.9 ± 6.3% 51.9 ± 9.6 50.4 ± 10.9 54.2 ± 2.8
LA size 4.6 ± 0.6 4.6 ± 0.5 4.8 ± 0.6 4.6 ± 0.5 4.7 ± 0.4
Mitral Regurgitation 1.7 ± 0.7 2.0 ± 0.7 2.1 ± 0.7 2.1 ± 0.6 1.7 ± 0.5
Pericardial
Effusion
5% 12% 0 0 0
ASD 30% 14% 14% 0 0
E/A ratio DT (ms) E/e' ratio LAV (ml/m2)
Age, per 10 yrs -17 (-19,-14)‡ 23 (18,27)‡ 17 (12,21)‡ 6 (3,10)†
Male gender 0 (-7,7) 14 (4,23)† -15 (-21,-8)‡ 3 (-4,10)
Clinical CAD -6 (-18,7) 24 (6,42)* 9 (-6,26) 20 (6,37)†
Plaques <4 mm thick -16 (-22,-10)‡§ 17 (6,28)‡§ 19 (9,30)‡§ 3 (-4,11)†§
Plaques 4-5 mm -21 (-29,-12) 23 (8,37) 27 (13,43) 20 (8,33)
Plaques >=6 mm -29 (-39,-19) 45 (24,66) 46 (24,73) 19 (3,37)
